GNH USA

Europe — EMA

Nerisona (Diflucortolone Valerate)

GNH USA supplies Nerisona (Diflucortolone Valerate), a topical corticosteroid for eczema, psoriasis and dermatitis. Request a quote for global supply.

Diflucortolone Valerate

Request sourcing

1
Pack/s

What is Diflucortolone Valerate?

Diflucortolone Valerate, the active ingredient in Nerisona, is a corticosteroid presented as a topical formulation for skin use. It is prescribed to reduce inflammation and relieve symptoms in various inflammatory skin disorders such as eczema, psoriasis and dermatitis.

GNH USA supplies Nerisona as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Diflucortolone Valerate used for?

Diflucortolone Valerate is a topical glucocorticoid used to manage inflammatory skin conditions.

- Eczema: reduces redness, itching and swelling. - Psoriasis: diminishes plaque formation and scaling. - Dermatitis: alleviates inflammation and discomfort. - Other inflammatory skin disorders: provides symptomatic relief where corticosteroid therapy is indicated.

What are the side effects of Diflucortolone Valerate?

Topical diflucortolone valerate may cause local and systemic reactions.

Common Side Effects: - Burning or stinging at the application site. - Pruritus or mild irritation. - Dryness or peeling of the skin. - Erythema or mild redness. - Folliculitis. - Acneiform eruptions.

Serious or Rare Side Effects: - Skin atrophy or thinning. - Telangiectasia (visible small blood vessels). - Secondary bacterial, fungal or viral infections. - Hypersensitivity reactions such as contact dermatitis. - Systemic corticosteroid effects with extensive use (e.g., adrenal suppression).

What precautions apply to Diflucortolone Valerate?

When using diflucortolone valerate, consider the following precautions.

- Apply only to intact skin: avoid broken or infected areas. - Limit duration: use for the shortest period needed to control symptoms. - Avoid occlusion unless directed: covering the area can increase absorption. - Monitor for signs of infection: discontinue if secondary infection develops. - Use with caution in children: higher risk of systemic absorption. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

What does Diflucortolone Valerate interact with?

Diflucortolone valerate may interact with other agents applied to the skin.

Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of systemic effects. - Potent immunosuppressants (e.g., tacrolimus): can exacerbate skin atrophy.

Moderate Interactions (Monitor Closely): - Antifungal or antibacterial topicals: may alter local flora and increase irritation. - Skin moisturizers containing alcohol or fragrances: can enhance irritation. - Phototherapy: combined use may increase skin sensitivity.

Frequently asked questions

What conditions is Nerisona used to treat?+
Nerisona, containing diflucortolone valerate, is prescribed for inflammatory skin disorders such as eczema, psoriasis, and various forms of dermatitis. It helps reduce redness, itching, swelling, and scaling associated with these conditions by delivering a potent topical corticosteroid effect directly to the affected skin.
How does diflucortolone valerate work in the skin?+
Diflucortolone valerate penetrates skin cells and binds to glucocorticoid receptors inside the nucleus. This receptor complex alters gene transcription, decreasing production of inflammatory cytokines, inhibiting leukocyte migration, and reducing vascular permeability. The overall result is a marked reduction in local inflammation and immune activity.
What is the usual dose of Nerisona?+
The specific amount, frequency and duration of Nerisona application are determined by the prescribing healthcare professional based on the severity of the skin condition, the area to be treated, and patient factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Nerisona safe to use during pregnancy or breastfeeding?+
Safety data for diflucortolone valerate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their physician.
How do I order Nerisona from GNH USA?+
To request Nerisona, visit the product page on gnh-usa.com, enter the required quantity and submit the enquiry form. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Nerisona compare with other topical steroids?+
Diflucortolone valerate is a high‑potency class II topical corticosteroid, offering stronger anti‑inflammatory activity than low‑potency agents like hydrocortisone but less potency than class I steroids such as clobetasol. It provides a balance of efficacy and safety for moderate to severe inflammatory dermatoses when used as directed.
What are the recommended storage conditions for Nerisona?+
Store Nerisona at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, excessive heat and direct sunlight. Do not freeze the preparation, and ensure the container is tightly closed when not in use.
How should Nerisona be applied?+
Apply a thin layer of Nerisona to the affected skin area once or twice daily, as instructed by the prescriber. Gently rub the cream or ointment until it disappears. Wash hands before and after application, and avoid contact with eyes, mucous membranes and open wounds unless directed.
What are the most serious risks associated with Nerisona?+
Serious risks include skin atrophy, telangiectasia, secondary infections, and systemic corticosteroid effects such as adrenal suppression when used over large areas or for prolonged periods. Patients should report any unusual thinning of the skin, persistent redness, or signs of infection to their healthcare provider promptly.
Who should not use Nerisona?+
Nerisona is contraindicated in patients with known hypersensitivity to diflucortolone valerate or any formulation excipients. It should also be avoided on viral, fungal or bacterial skin infections unless combined with appropriate antimicrobial therapy, and in individuals with untreated skin tuberculosis or severe skin atrophy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Diflucortolone Valerate
Route
Cutaneous Use
Manufacturer
Leo Pharma A/S
Origin
EU

Related products

Claral

Claral

Diflucortolone Valerate

Leo Pharma A/S
EU
Dermaval

Dermaval

Diflucortolone Valerate

Morgan Srl
EU
Dervin

Dervin

Diflucortolone Valerate

Bionativa S.P.A.
EU
Flu Cortanest

Flu Cortanest

Diflucortolone Valerate

Piam Farmaceutici Spa
EU